Unlock stock picks and a broker-level newsfeed that powers Wall Street.
6.30
-0.04
(-0.63%)
At close: 4:00:00 PM EDT
6.30
0.00
(0.00%)
After hours: 4:05:11 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.41 | -0.44 | -3.26 | -2.16 |
| Low Estimate | -1.06 | -1.12 | -10.46 | -5.76 |
| High Estimate | -0.19 | -0.18 | -0.76 | -0.82 |
| Year Ago EPS | -3.12 | -1.83 | -1.15 | -3.26 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 5 | 5 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -3.06 | -2.25 | -1.37 | -0.43 |
| EPS Actual | -3.12 | -1.83 | -0.19 | -0.18 |
| Difference | -0.06 | 0.42 | 1.18 | 0.25 |
| Surprise % | -1.96% | 18.67% | 86.13% | 57.65% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.41 | -0.44 | -3.26 | -2.16 |
| 7 Days Ago | -0.49 | -0.52 | -3.37 | -2.18 |
| 30 Days Ago | -0.68 | -0.78 | -2.7 | -1.72 |
| 60 Days Ago | -0.17 | -0.2 | -1.05 | -1.71 |
| 90 Days Ago | -0.17 | -0.2 | -1.05 | -1.71 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 2 | 1 | 1 |
| Down Last 7 Days | 2 | 1 | 3 | 2 |
| Down Last 30 Days | 2 | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| TENX | 86.86% | 76.23% | -183.48% | 33.59% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Initiated | Leerink Partners: Outperform | 10/24/2024 |
| Reiterates | Roth MKM: Buy to Buy | 2/20/2024 |
Related Tickers
VTVT vTv Therapeutics Inc.
17.50
+6.71%
AKTX Akari Therapeutics, Plc
1.1000
-4.35%
PULM Pulmatrix, Inc.
6.06
-2.26%
TYRA Tyra Biosciences, Inc.
8.65
-0.80%
PALI Palisade Bio, Inc.
0.6676
-0.33%
ZVSA ZyVersa Therapeutics, Inc.
0.5873
-0.03%
ENSC Ensysce Biosciences, Inc.
2.6400
+5.60%
ATXI Avenue Therapeutics, Inc.
0.2621
-12.63%
BPTH Bio-Path Holdings, Inc.
0.1702
+3.15%
MLYS Mineralys Therapeutics, Inc.
14.00
+1.16%